Trending
Stocks.org
You are at:»»Biotech Watch List: Novavax (NASDAQ:NVAX), Idera Pharmaceuticals (NASDAQ:IDRA), Insmed Incorporated (NASDAQ:INSM), Inovio Pharmaceuticals (NYSEMKT:INO)

Biotech Watch List: Novavax (NASDAQ:NVAX), Idera Pharmaceuticals (NASDAQ:IDRA), Insmed Incorporated (NASDAQ:INSM), Inovio Pharmaceuticals (NYSEMKT:INO)

606
By on Market

Novavax, Inc. (NASDAQ:NVAX) Investor confidence was whipped up in the stock Tuesday after the company disclosed that Richard Douglas, a director of the company, purchased 50,000 shares of the company. On last trading day Novavax, Inc. (NASDAQ:NVAX) ended up -1.79%lower to close at $4.40 while trading in the range of $4.35 – $4.76. Its return on assets (ROA) is -34.10% while return on investment (ROI) is -36.40%.Novavax, Inc. (NASDAQ:NVAX) monthly performance is -27.63%.

Cowen and Company started coverage on shares of Idera Pharmaceuticals (NASDAQ:IDRA) in a research report released on Monday morning, TheFlyOnTheWall.com reports. The firm issued an outperform rating on the stock. Idera Pharmaceuticals Inc. (NASDAQ:IDRA) in last trading activity ended up at $4.19 with day range of $3.88 – $4.64. Company weekly performance is -36.42% while its quarterly performance stands at 33.44%.Idera Pharmaceuticals Inc. (NASDAQ:IDRA) is -39.01% away from its 52 week high.

Insmed Incorporated (NASDAQ:INSM) yesterday reported results from the Company’s phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment resistant nontuberculous mycobacterial (NTM) lung infections. Insmed Incorporated (NASDAQ:INSM) belongs to Healthcare sector with market capitalization of 623.30 million and has 1.60% insider ownership. In last trading activity company’s stock closed at $15.90 while opening price was $16.00.

Inovio Pharmaceuticals Inc. announced that it was recognized with three industry awards at the World Vaccine Congress, being held this week in Washington, D.C. The On Wednesday shares of Inovio Pharmaceuticals Inc. (NYSEMKT:INO) opened at $3.34 and closed at $3.23. This Year Company’s Earnings per Share (EPS) growth is -0.35 and next year’s estimated EPS growth is -33.30%. Analysts mean target price for Inovio Pharmaceuticals Inc. (NYSEMKT:INO) is $4.60.

Get Free Updates and Stock Alerts!



*We only send one email per week
Share.

Related Posts

Get Winning Stock Alerts!

Our track record speaks for itself! Our last 7 alerts have delivered combined gains in excess of 300% and there are no signs of slowing down. Join UltimateStockAlerts.com now before you miss out on our next big runner!

We will never sell or share your information.
Close